NPI: 1750746285 · LA PORTE, IN 46350 · General Acute Care Hospital · NPI assigned 12/29/2015
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 12/29/2015 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 59,133 | $1.18M |
| 2019 | 47,708 | $1.73M |
| 2020 | 43,304 | $1.84M |
| 2021 | 54,256 | $3.46M |
| 2022 | 78,953 | $5.00M |
| 2023 | 75,864 | $4.73M |
| 2024 | 51,152 | $2.94M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 29,094 | 23,997 | $4.22M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 20,274 | 15,511 | $2.93M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 17,967 | 5,609 | $2.26M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,592 | 1,157 | $1.18M |
| 71045 | Radiologic examination, chest; single view | 7,652 | 5,960 | $1.01M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7,819 | 2,469 | $846K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 6,635 | 2,035 | $833K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 482 | 393 | $717K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,512 | 1,084 | $575K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,693 | 2,822 | $545K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 830 | 258 | $538K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,566 | 5,258 | $469K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 336 | 197 | $317K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,223 | 839 | $313K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4,662 | 3,865 | $300K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,091 | 1,795 | $299K |
| 80050 | General health panel | 1,874 | 1,728 | $241K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,599 | 729 | $226K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7,567 | 6,232 | $188K |
| 80053 | Comprehensive metabolic panel | 34,019 | 24,824 | $178K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 41,886 | 30,140 | $167K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,542 | 2,041 | $148K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 425 | 255 | $133K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,055 | 1,706 | $120K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,400 | 1,845 | $117K |
| 36415 | Collection of venous blood by venipuncture | 53,656 | 39,158 | $115K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 74 | 56 | $113K |
| 62323 | 151 | 98 | $111K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,993 | 3,385 | $105K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3,996 | 3,388 | $105K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,222 | 4,803 | $92K |
| 70450 | Computed tomography, head or brain; without contrast material | 785 | 591 | $86K |
| 71046 | Radiologic examination, chest; 2 views | 969 | 696 | $79K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,842 | 1,514 | $78K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9,194 | 7,270 | $72K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 817 | 737 | $65K |
| 87660 | 4,229 | 3,646 | $61K | |
| 87480 | 4,210 | 3,630 | $60K | |
| 87510 | 4,212 | 3,630 | $60K | |
| 88142 | 4,153 | 3,751 | $48K | |
| 11043 | 57 | 24 | $40K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,536 | 2,927 | $33K |
| 81001 | 18,520 | 14,406 | $32K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,118 | 996 | $32K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,888 | 2,917 | $31K |
| 43193 | 22 | 13 | $29K | |
| 93017 | 506 | 316 | $27K | |
| 81025 | 4,522 | 3,577 | $25K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 214 | 162 | $24K |
| 84484 | 3,343 | 2,028 | $24K | |
| 76830 | Ultrasound, transvaginal | 117 | 104 | $24K |
| 80061 | Lipid panel | 3,142 | 2,561 | $23K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 179 | 150 | $23K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 101 | 38 | $22K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,705 | 3,069 | $21K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,122 | 941 | $19K |
| 87150 | 587 | 545 | $19K | |
| 31231 | 75 | 57 | $19K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 136 | 108 | $17K |
| 86803 | 1,415 | 1,178 | $14K | |
| 83690 | 3,765 | 2,783 | $13K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 67 | 51 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 903 | 808 | $11K |
| 86850 | 2,508 | 2,047 | $10K | |
| 83735 | 3,023 | 2,159 | $10K | |
| 87040 | 1,829 | 715 | $10K | |
| 86762 | 852 | 703 | $9K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 354 | 323 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 709 | 537 | $7K |
| 97162 | 47 | 43 | $6K | |
| 86592 | 2,014 | 1,705 | $6K | |
| 99221 | 19 | 14 | $6K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 19 | 14 | $6K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 53 | 48 | $6K |
| 87653 | 252 | 231 | $6K | |
| 83605 | 1,006 | 662 | $6K | |
| 85730 | 2,010 | 1,491 | $5K | |
| 87340 | 865 | 715 | $5K | |
| 86900 | 2,511 | 2,049 | $5K | |
| 93226 | 18 | 12 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 93 | 71 | $5K |
| 83655 | 428 | 396 | $5K | |
| 86901 | 2,506 | 2,046 | $5K | |
| 97165 | 47 | 39 | $5K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 188 | 131 | $5K |
| 88342 | 364 | 253 | $5K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 21 | 13 | $5K |
| 83880 | 329 | 232 | $5K | |
| 82728 | 527 | 423 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,021 | 884 | $5K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 34 | 27 | $5K |
| 80074 | 109 | 102 | $5K | |
| 52000 | 17 | 13 | $4K | |
| 82950 | 1,081 | 902 | $4K | |
| 85660 | 872 | 723 | $4K | |
| 85610 | 2,034 | 1,517 | $4K | |
| 85027 | 574 | 531 | $4K | |
| 82077 | 289 | 235 | $3K | |
| 93296 | 51 | 27 | $3K | |
| 83550 | 422 | 341 | $3K | |
| 84702 | 236 | 166 | $3K | |
| 88304 | 312 | 236 | $2K | |
| 83540 | 422 | 341 | $2K | |
| 84436 | 542 | 391 | $2K | |
| 87807 | 107 | 91 | $1K | |
| 96367 | 38 | 14 | $1K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 246 | 216 | $984.03 |
| 84439 | 504 | 452 | $981.26 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 358 | 279 | $898.00 |
| 59025 | Fetal non-stress test | 68 | 24 | $879.57 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13 | 13 | $800.44 |
| 85379 | 45 | 40 | $424.47 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 110 | 91 | $423.52 |
| 93225 | 39 | 25 | $410.96 | |
| 80076 | 54 | 53 | $407.39 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 135 | 105 | $392.34 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 18 | 14 | $378.27 |
| 82150 | 161 | 108 | $365.64 | |
| 84146 | 31 | 25 | $315.13 | |
| 82247 | 65 | 58 | $311.24 | |
| 81000 | 187 | 107 | $182.22 | |
| 82607 | 17 | 12 | $150.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 30 | 24 | $147.76 |
| 82550 | 65 | 40 | $144.39 | |
| 80055 | 15 | 12 | $110.55 | |
| 87109 | 18 | 14 | $92.10 | |
| 82553 | 37 | 28 | $73.17 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 917 | 685 | $68.66 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,656 | 2,133 | $40.51 |
| J2704 | Injection, propofol, 10 mg | 3,681 | 2,651 | $6.55 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,608 | 1,354 | $0.89 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,459 | 2,726 | $0.46 |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,619 | 1,288 | $0.00 |
| J1245 | Injection, dipyridamole, per 10 mg | 20 | 13 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 90 | 68 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 12 | 12 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 13 | 12 | $0.00 |
| 88313 | 122 | 87 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 86 | 54 | $0.00 |
| J3490 | Unclassified drugs | 38 | 36 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 291 | 225 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,852 | 1,526 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 378 | 357 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 30 | 30 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 553 | 478 | $0.00 |
| 90744 | 424 | 384 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 33 | 25 | $0.00 |
| L8699 | Prosthetic implant, not otherwise specified | 94 | 77 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 42 | 25 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 15 | 12 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 30 | 26 | $0.00 |